Matthew C. Abernethy
2018
Compensation breakdown
| Bonus | $199,500 |
|---|---|
| Salary | $420,000 |
| Stock Awards | $1,996,506 |
| Other | $69,741 |
| Total | $2,685,747 |
Abernethy received $2M in stock awards, accounting for 74% of the total pay in 2018.
Abernethy also received $199.5K in bonus, $420K in salary and $69.7K in other compensation.
Rankings
In 2018, Matthew C. Abernethy's compensation ranked 4,349th out of 14,244 executives tracked by ExecPay. In other words, Abernethy earned more than 69.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,349 out of 14,244 | 70th |
Division Manufacturing | 1,615 out of 5,762 | 72nd |
Major group Chemicals And Allied Products | 579 out of 2,125 | 73rd |
Industry group Drugs | 483 out of 1,814 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 95 out of 339 | 72nd |
Pay ratio
| Matthew C. Abernethy's Pay | $2,685,747 |
|---|---|
| Median Employee's Pay | $259,000 |
| Pay Ratio | 10to 1 |
In 2018, the annual total compensation of Matthew C. Abernethy was $2,685,747.
The annual total compensation of the median employee at Neurocrine Biosciences was $259,000.
The ratio of Matthew C. Abernethy's pay to the pay of median employee was therefore 10 to one.
Abernethy's colleagues
We found five more compensation records of executives who worked with Matthew C. Abernethy at Neurocrine Biosciences in 2018.
2018
Kevin Gorman
Neurocrine Biosciences
Chief Executive Officer
2018
Eiry Roberts
Neurocrine Biosciences
Chief Medical Officer
2018
Kyle Gano
Neurocrine Biosciences
Chief Business Development Officer
2018
Eric Benevich
Neurocrine Biosciences
Chief Commercial Officer
2018
Haig Bozigian
Neurocrine Biosciences
Chief Development Officer
News
April 7, 2022
April 9, 2021
April 9, 2020
April 17, 2019